Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Zelda Therapeutics Ltd (OP: ZLDAF )

0.4500 UNCHANGED
Last Price Updated: 12:16 PM EST, Nov 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zelda Therapeutics Ltd

< Previous 1 2 3 Next >
Marijuana Stock Movers For August 9, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bearish Monday For Marijuana Stocks - EVIO, Item 9 Labs Among Top Gainers
Via Benzinga
Marijuana Stock Movers For August 8, 2023
Via Benzinga
This Cannabis-Based Drug Has Outperformed Pfizer's Lyrica In Clinical Trials: A New Dawn For Diabetic Nerve Pain Management?
Zelira Therapeutics Ltd (ASX: ZLD) (OTCQB: ZLDAF), a leading player in cannabinoid medicine research, has successfully demonstrated that its proprietary drug for diabetic nerve pain, ZLT-L-007,... 
Via Benzinga
Cannabis Stock Gainers And Losers From July 28, 2023
Via Benzinga
Medical Cannabis For Autism: Zelira Receives $8.6M For FDA Clinical Trials For Treatment
Zelira Therapeutics Ltd (ASX: ZLD) (OTCQB: ZLDAF), a developer of cannabinoid-based medicines, will conduct FDA Phase 2 and Phase 3 clinical trials for its HOPE-1 treatment of Autism Spectrum Disorder... 
Via Benzinga
Cannabis Stock Gainers And Losers From July 26, 2023
Via Benzinga
A Global List Of Cannabis Operators And Executives To Keep An Eye On In 2022 And Beyond
Less than 30 years after Israel became the first nation in the world to allow its citizens to use cannabis for medical purposes, the medical and adult-use cannabis markets have spread across the globe... 
Via Benzinga
Cannabis Stock Movers For July 19, 2023
Via Benzinga
Sun, Water, Weed And B2B?: What Opportunities Can Cannabis Investors Expect From This Conference In Panama
By Franca Quarneti via El Planteo. 
Via Benzinga
Zelira's Zenivol, Clinically Validated Cannabinoid Medication For Insomnia, Gets Regulatory Approval In Germany
Zelira Therapeutics Ltd’s (OTCQB: ZLDAF) (ASX:ZLD) insomnia medication Zenivol has achieved formal approval from German regulatory authority BfArM to launch in the German medical cannabis market. 
Via Benzinga
Cannabis Goes Head-to-Head With Big Pharma In New Zelira Therapeutics Pain Med Study
Zelira Therapeutics (OTC: ZLDAF), a global leader in the research, development and commercialization of clinically validated cannabinoid medicines, is about to begin the first-ever clinical trial of... 
Via Benzinga
EXCLUSIVE: Cannabis Co. Zelira Therapeutics Acquires Health House International
Zelira Therapeutics Ltd (ASX: ZLD) (OTCQB:ZLDAF) is acquir... 
Via Benzinga
September Summary: Cannabis-Based Vs. Psychedelic Compounds-Based Drug Stock Performances
Which index out-performed in September, the Pure-Play Marijuana-Based Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index? 
Via Talk Markets
Zelira Lands In Germany With Distribution Agreement For Cannabinoid Sleep Medication
Australia-based Zelira Therapeutics Ltd. (OTCQB:ZLDAF), a ... 
Via Benzinga
Marijuana Drug Stocks: All You Need To Know Is Here!
Eight clinical-stage companies researching the treatment of a wide variety of illnesses using marijuana of which 6 have market capitalizations in excess of $50M and less than $500M and 2 have market... 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Mixed Feelings About Cannabis Stocks, Check Out How The Top Movers Did On August 3, 2021
GAINERS: Cipher Pharms Inc (OTC: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bullish Sentiment Pumps Up Cannabis Stocks: Tilray, Sundial, Aurora & GrowGen Among Top Cannabis Movers For July 20, 2021
GAINERS: Empower Clinics (OTC: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
World Acceptance, Cresco Labs And TerrAscend Among Top Cannabis Stock Movers On July 15, 2021
GAINERS: Benchmark Botanics (OTC: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bearish Sentiment On The Marijuana Market: Cannabis Movers For July 14, 2021
GAINERS: CURE Pharmaceutical Hldg (O... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
General Cannabis, MariMed & Urban-Gro Among Top Cannabis Stock Movers On July 13, 2021
GAINERS: CURE Pharmaceutical Hldg (O... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Rhinomed, Zelira And Alcanna Among Top Cannabis Stock Movers On July 12, 2021
GAINERS: Origin Agritech (NASDAQ: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Australis, CV Sciences And MedMen Among Top Cannabis Stock Movers On July 9, 2021
GAINERS: Livewell Canada Inc (OTC: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
International Rising Stars: 9 Cannabis CEOs To Keep An Eye On
By Cynthia Salarizadeh, House of Saka. Less than 3... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
22nd Century Group, CLS Holdings, Zelira And Cresco Among Top Cannabis Stock Movers On June 30, 2021
GAINERS: RIV Capital (OTC: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Item 9 Labs, TerrAscend, MariMed And MedMen Among Top Cannabis Stock Movers On June 29, 2021
GAINERS: Canada House Wellness (OTC... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From June 17, 2021
GAINERS: Invictus MD Strategies (OT... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Week In Cannabis: Federal Research Bill, George Lopez, Brazil, Morocco, Columbia Care And More
As we near the end of the first half of 2021, we can see cannabis stocks traded mostly up by double digits, with the Amplify Seymour Cannab... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From June 10, 2021
GAINERS: Cipher Pharms Inc (OTC: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Exclusive: Cannabis Co. Zelira To Begin Clinical Trials For Chronic Pain In Retired Athletes
Global cannabis research company Zelira Therapeutics (ASX: ZLD) (OTCQB: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.